【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Disease overview
• Understanding postmenopausal osteoporosis
• Epidemiology and demography
• Risk factors
• Symptoms
• Diagnosis
• Treatment
PART 06: Key buying criteria
PART 07: Pipeline scenario
• TBRIA
• Romosozumab (AMG785)
• Odanacatib (MK-0822)
• Abaloparatide SC/Abaloparatide transdermal patch
• PHN-031 (PH3)
• NB S101
• Teriparatide ZP Patch (ZP-PTH)
• Blosozumab (LY2541546)
PART 08: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 09: Market segmentation by therapeutic class
• Antiresorptive medications
• Anabolic medications
PART 10: Market segmentation by line of therapy
PART 11: Geographical segmentation
• Global postmenopausal osteoporosis drugs market by geographical segmentation 2015-2020
• Postmenopausal osteoporosis drugs market in Americas
• Postmenopausal osteoporosis drugs market in EMEA
• Postmenopausal osteoporosis drugs market in APAC
PART 12: Market drivers
• Increase in older population
• Growing prevalence of postmenopausal osteoporosis
• Expected launch of promising pipeline molecules
• High unmet medical needs
PART 13: Impact of drivers
PART 14: Market challenges
• Multiple patent expiries
• Low diagnosis rate
• Nonadherence to treatment regimen
• Drug reimbursement issues
PART 15: Impact of drivers and challenges
PART 16: Market trends
• Awareness programs and initiatives
• Emergence of novel agents
• Emergence of combination therapies
PART 17: Vendor landscape
• Competitive scenario
• Market analysis 2015
• Eli Lilly
• Amgen
• Merck
• Novartis
• Other prominent vendors
PART 18: Appendix
• List of abbreviations
PART 19: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Prevalence of osteoporosis based on gender 2015
Exhibit 03: Interpretation of BMD results
Exhibit 04: Timeline for development of osteoporosis drugs
Exhibit 05: Key buying criteria for postmenopausal osteoporosis drugs
Exhibit 06: Pipeline portfolio: Postmenopausal osteoporosis
Exhibit 07: Global postmenopausal osteoporosis drugs market 2015-2020 ($ billions)
Exhibit 08: Five forces analysis
Exhibit 09: Segmentation of global postmenopausal osteoporosis drugs market by therapeutic class
Exhibit 10: Segmentation of global postmenopausal osteoporosis drugs market by therapeutic class on basis of revenue 2015
Exhibit 11: Segmentation of global postmenopausal osteoporosis drugs market by line of therapy
Exhibit 12: Segmentation of global postmenopausal osteoporosis drugs market by line of therapy on basis of revenue 2015
Exhibit 13: Segmentation of global postmenopausal osteoporosis drugs market based on geography 2015
Exhibit 14: Global postmenopausal osteoporosis drugs market by geography 2015-2020 ($ billions)
Exhibit 15: Global postmenopausal osteoporosis drugs market by geography 2015-2020
Exhibit 16: Postmenopausal osteoporosis drugs market in Americas 2015-2020 ($ billions)
Exhibit 17: Postmenopausal osteoporosis drugs market in EMEA 2015-2020 ($ billions)
Exhibit 18: Postmenopausal osteoporosis drugs market in APAC 2015-2020 ($ billions)
Exhibit 19: Global postmenopausal osteoporosis drugs market: YoY growth and revenue based on geography 2015-2020
Exhibit 20: Percentage share of women in age group of 60 years and older 2015
Exhibit 21: Percentage share of women in age group of 80 years and above 2015
Exhibit 22: Impact of drivers
Exhibit 23: Impact of drivers and challenges
Exhibit 24: Revenue from sales of major drugs in global postmenopausal osteoporosis drugs market 2013-2015 ($ millions)
Exhibit 25: Eli Lilly: YoY revenue and growth rate of FORTEO 2015 ($ billions)
Exhibit 26: Eli Lilly: Geographical segmentation of FORTEO 2015
Exhibit 27: Eli Lilly: YoY revenue and growth rate of Evista 2015 ($ millions)
Exhibit 28: Eli Lilly: Geographical segmentation of Evista 2015
Exhibit 29: Eli Lilly: Key takeaways
Exhibit 30: Amgen: YoY revenue and growth rate of Prolia 2013-2015 ($ millions)
Exhibit 31: Amgen: Geographical segmentation of Prolia 2015
Exhibit 32: Amgen: Key takeaways
Exhibit 33: Merck: YoY revenue and growth rate of Fosamax 2013-2015 ($ millions)
Exhibit 34: Merck: Key takeaways
Exhibit 35: Novartis: Key takeaways
【レポート販売概要】
■ タイトル：閉経後骨粗鬆症治療薬の世界市場2016-2020■ 英文：Global Postmenopausal Osteoporosis Drugs Market 2016-2020
■ 発行日：2016年5月11日
■ 調査会社：Technavio
■ 商品コード：IRTNTR9271
■ 調査対象地域：グローバル
- フレキシブルAC伝送システム（FACTS）の世界市場予測（～2024年）FACTS market to grow at CAGR of 6.0% from 2019 to 2024 The global flexible AC transmission systems (FACTS) market size is projected to reach USD 1.7 billion by 2024 from USD 1.2 billion in 2019, at a CAGR of 6.0%. Major drivers for the market’s growth are increasing benefits offered by FACTS, growth in transmission line, rising focus on energy generation using renewable sources, and surging demand …
- ビル及び構築分野プラスチックのグローバル市場動向2011-2016（Building & Construction Plastics – A Global Market Watch, 2011 – 2016）Global Market Watch: With a CAGR of 7.0%, global market value for plastics in building & construction application market is anticipated to be worth US$45.6 billion by 2016. On a global scale, Europe accounts for more than 30% of the market. While US accounts for the largest share of the global market value on a country basis, India and Japan surpasses the US in terms of growth rate anticipated in …
- Intraocular Lens Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018Intraocular Lens Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Summary GlobalData’s new report, “Intraocular Lens Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides key market data on the Intraocular Lens (IOL) market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data for each segment …
- 企業内教育の世界市場2016-2020About Corporate TrainingCompanies are expanding their businesses worldwide, leading to intense competition in recruitment, training, and retaining talent. Advanced tools and technologies are available in the market to help organizations design and develop training programs for employees irrespective of the location of the delivery center. Technavio’s analysts forecast the global corporate training …
- LEDライトエンジンの世界市場展望2017-2026According to Stratistics MRC, the Global LED Light Engine Market is accounted for $21.88 billion in 2017 and is expected to reach $84.53 billion by 2026 growing at a CAGR of 16.2% during the forecast period. The increasing consumer demand for energy-efficient lighting systems, reduction in prices of LEDs, and high penetration of LEDs as a light source in the general lighting market are expected to …
- 2014年戦略提言：RSウイルスの診断検査市場The report presents a detailed analysis of the Respiratory Syncytial Virus diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Respiratory Syncytial Virus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: …
- EEG/ECGバイオメトリクス（生体認証）の世界市場About EEG and ECG Biometrics EEG biometric technology measures and records the electrical activity of the brain. These electrical patterns are analyzed for authentication and stored for further reference. ECG is a diagnostic tool that helps assess the electrical activity of an individual's heart. When it is integrated with biometric solutions, it is used for authentication purposes as every indivi …
- 動脈石灰化：治療薬のグローバル治験動向（2014年下半期）Arterial Calcification Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Arterial Calcification Global Clinical Trials Review, H2, 2014" provides data on the Arterial Calcification clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Arterial Calcification. It includes an overview of the trial numbers and …
- 再発性多発性硬化症(RMS)治療のグローバル臨床試験動向（2014年下半期）Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2014" provides data on the Relapsing Multiple Sclerosis (RMS) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Relapsing Multiple Sclerosis (RMS). …
- フィブリノゲン欠乏症(Fibrinogen Deficiency)：治療薬開発パイプライン動向（2015年上半期版）Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H1 2015’, provides an overview of the Fibrinogen Deficiency (Factor I Deficiency)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Fibrinogen Deficiency (Factor I Deficiency), …
- 圧縮空気式電力貯蔵システムの世界市場2015-2019About Compressed Air Energy Storage Compressed air energy storage, as the name suggests, is a technique for storing energy by using compressed air. Energy is generally stored for utilizing it later to meet the high demand during peak hours. Growing interest in energy storage by utilizing renewable energy source has led to an upsurge in new and more advanced energy storage techniques. Compressed ai …
- BIPV（建材一体型太陽光発電）技術及び世界市場2015-2022This report provides guidance on the new economics of BIPV in a new business environment where demand patterns have changed and subsidies have begun to disappear. It shows how BIPV products can be classified into types based on intelligence and functionality and how each type fits into its own characteristic niche. Supply chain issues are prominently discussed. The report explores the strategies o …
- 網膜用治療薬の世界市場2018-2022About Retinal Drugs Retinal drugs are the medications that are used for the treatment of retinal diseases. Technavio’s analysts forecast the global retinal drugs market to grow at a CAGR of 7.63% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth prospects of the global retinal drugs market for 2018-2022. To calculate the market size, the repo …
- 医療リフトスリングの世界市場予測The report segments the medical lifting slings market by product, usage type, material, end user and region. The transfer sling segment is expected to be the largest segment and it also has the fastest growth rate in the forecast period. Universal slings segment is the second leading segment in terms of growth rate and market share. This growth can be attributed to the universal application of thi …
- ロボットカー/無人車の世界市場分析、セグメント予測The global autonomous cars market is expected to reach 138,089 units by 2024, according to a new study by Grand View Research, Inc. The growing acceptance of semi-autonomous technologies, such as Adaptive Cruise Control (ACC), automatic parking, and forward collision avoidance, is anticipated to pave the way for the adoption of driverless automobiles over the next seven years. An upsurge in the de …
